[{"address1": "1065 East Hillsdale Boulevard", "address2": "Suite 100", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 525 5535", "fax": "650 275 4254", "website": "https://www.ternspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates for the treatment of oncology and obesity. The company develops TERN-701, an allosteric BCR-ABL tyrosine kinase inhibitor (TKI) that is in Phase 1 clinical trial for chronic myeloid leukemia (CML), a form of cancer that starts in bone marrow. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase IIa clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis (MASH); and TERN-601, a small-molecule Glucagon-Like Peptide-1 receptor agonist program that is intended to orally be administered for obesity, as well as TERN-800 series of small-molecule glucose-dependent insulinotropic polypeptide receptor (GIPR) modulators for obesity. The company was incorporated in 2016 and is headquartered in Foster City, California.", "fullTimeEmployees": 59, "companyOfficers": [{"maxAge": 1, "name": "Ms. Amy L. Burroughs M.B.A.", "age": 54, "title": "CEO & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1007081, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melita Sun Jung", "age": 47, "title": "Chief Business Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 508886, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew W. Gengos", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caryn Gordon McDowell J.D.", "age": 54, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeffrey R. Jasper Ph.D.", "title": "Senior Vice President of Research", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emil T. Kuriakose M.D.", "age": 44, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Scott  Harris", "title": "Chief Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Debra  Sieminski", "title": "Senior Vice President of Medical Affairs", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Kanter", "title": "Senior VP of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yasameen  Qazen", "title": "Senior VP of Regulatory Affairs & Quality Assurance", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 5, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.26, "open": 4.3, "dayLow": 4.21, "dayHigh": 4.35, "regularMarketPreviousClose": 4.26, "regularMarketOpen": 4.3, "regularMarketDayLow": 4.21, "regularMarketDayHigh": 4.35, "payoutRatio": 0.0, "beta": -0.194, "forwardPE": -3.1079137, "volume": 263302, "regularMarketVolume": 263302, "averageVolume": 940604, "averageVolume10days": 847610, "averageDailyVolume10Day": 847610, "bid": 3.14, "ask": 5.47, "bidSize": 2, "askSize": 2, "marketCap": 377299296, "fiftyTwoWeekLow": 1.865, "fiftyTwoWeekHigh": 11.4, "fiftyDayAverage": 3.4215, "twoHundredDayAverage": 4.94025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -7259002, "profitMargins": 0.0, "floatShares": 58910220, "sharesOutstanding": 87337800, "sharesShort": 5942761, "sharesShortPriorMonth": 5458606, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.068, "heldPercentInsiders": 0.00278, "heldPercentInstitutions": 1.0023999, "shortRatio": 7.49, "shortPercentOfFloat": 0.0681, "impliedSharesOutstanding": 87337800, "bookValue": 3.735, "priceToBook": 1.1566266, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -90388000, "trailingEps": -1.08, "forwardEps": -1.39, "enterpriseToEbitda": 0.07, "52WeekChange": -0.4262948, "SandP52WeekChange": 0.12677538, "quoteType": "EQUITY", "currentPrice": 4.32, "targetHighPrice": 34.0, "targetLowPrice": 14.0, "targetMeanPrice": 19.14286, "targetMedianPrice": 17.0, "recommendationMean": 1.66667, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 334264000, "totalCashPerShare": 3.827, "ebitda": -103560000, "totalDebt": 1235000, "quickRatio": 30.568, "currentRatio": 30.887, "debtToEquity": 0.379, "returnOnAssets": -0.2215, "returnOnEquity": -0.32123002, "freeCashflow": -44953500, "operatingCashflow": -71658000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TERN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NMS", "messageBoardId": "finmb_558294166", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "Terns Pharmaceuticals, Inc.", "shortName": "Terns Pharmaceuticals, Inc.", "regularMarketChangePercent": 1.40845, "regularMarketPrice": 4.32, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1751568564, "regularMarketTime": 1751562000, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1612535400000, "postMarketChangePercent": 0.4629625, "postMarketPrice": 4.34, "postMarketChange": 0.01999998, "regularMarketChange": 0.0599999, "regularMarketDayRange": "4.21 - 4.35", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 940604, "fiftyTwoWeekLowChange": 2.4550002, "fiftyTwoWeekLowChangePercent": 1.3163539, "fiftyTwoWeekRange": "1.865 - 11.4", "fiftyTwoWeekHighChange": -7.0799994, "fiftyTwoWeekHighChangePercent": -0.6210526, "fiftyTwoWeekChangePercent": -42.62948, "earningsTimestamp": 1746734608, "earningsTimestampStart": 1754305140, "earningsTimestampEnd": 1754654400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.08, "epsForward": -1.39, "epsCurrentYear": -1.19178, "priceEpsCurrentYear": -3.6248302, "fiftyDayAverageChange": 0.8985002, "fiftyDayAverageChangePercent": 0.26260418, "twoHundredDayAverageChange": -0.62024975, "twoHundredDayAverageChangePercent": -0.12555027, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-05", "averageAnalystRating": "1.7 - Buy", "cryptoTradeable": false, "displayName": "Terns Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-07-05"}]